Subscribe for the Emerj "AI in Life Sciences Pulse" Newsletter

Leaders at some of the world's most respected Life Sciences organizations subscribe to Emerj:

Trending Life Sciences Podcast Episodes

Trending AI in Life Sciences Content

Clinical Reporting 
and Drug Discovery@2x

Clinical Reporting and Drug Discovery: An Overview of AI’s Impact in the Pandemic

The importance of AI in the pharmaceutical space has grown exponentially over the last few years, spearheaded by global demand for a COVID vaccine at the pandemic’s apex. Moreover, AI has proven helpful throughout the pandemic, all while providing glimpses into the future promise of the technology. 

AI Impact in EMEA@2x

AI Impact in EMEA – Advice from Leaders in Banking, Insurance, Life Sciences and More

This article is sponsored by SambaNova, and was written, edited and published in alignment with our transparent Emerj sponsored content guidelines.

Two NLP Use-Cases in Drug Discovery and Clinical Trials

Two NLP Use-Cases in Drug Discovery and Clinical Trials

This article was originally written as part of a PDF report sponsored by expert.ai, and was written, edited and published in alignment with our transparent Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.

The AI Behind DeepMind's Alphafold 950x540

The AI Behind DeepMind’s AlphaFold – and its Implications for the Future of Drug Discovery

This is a contributed article by Kristóf Zsolt Szalay. Kristóf is Founder and CTO at Turbine.AI, and holds a PhD in molecular biology and bioinformatics. To inquire about contributed articles from outside experts, contact [email protected].

Emerj CEO Presented at the OECD's Symposium Artificial Intelligence for Science, Industry and Society

Emerj CEO Keynotes OECD’s Symposium on AI for Pharma R&D

Event Title: Symposium Artificial Intelligence for Science, Industry and Society